Stockreport

Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025

Oculis Holding AG - Ordinary shares  (OCS) 
PDF ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing in [Read more]